1. Home
  2. AURA vs DHIL Comparison

AURA vs DHIL Comparison

Compare AURA & DHIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • DHIL
  • Stock Information
  • Founded
  • AURA 2007
  • DHIL 1990
  • Country
  • AURA United States
  • DHIL United States
  • Employees
  • AURA N/A
  • DHIL N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • DHIL Investment Managers
  • Sector
  • AURA Health Care
  • DHIL Finance
  • Exchange
  • AURA Nasdaq
  • DHIL Nasdaq
  • Market Cap
  • AURA 390.0M
  • DHIL 386.7M
  • IPO Year
  • AURA 2021
  • DHIL 1995
  • Fundamental
  • Price
  • AURA $6.00
  • DHIL $137.45
  • Analyst Decision
  • AURA Strong Buy
  • DHIL
  • Analyst Count
  • AURA 6
  • DHIL 0
  • Target Price
  • AURA $22.33
  • DHIL N/A
  • AVG Volume (30 Days)
  • AURA 191.8K
  • DHIL 47.4K
  • Earning Date
  • AURA 08-07-2025
  • DHIL 07-29-2025
  • Dividend Yield
  • AURA N/A
  • DHIL 4.38%
  • EPS Growth
  • AURA N/A
  • DHIL 0.69
  • EPS
  • AURA N/A
  • DHIL 14.79
  • Revenue
  • AURA N/A
  • DHIL $151,916,411.00
  • Revenue This Year
  • AURA N/A
  • DHIL N/A
  • Revenue Next Year
  • AURA N/A
  • DHIL N/A
  • P/E Ratio
  • AURA N/A
  • DHIL $9.29
  • Revenue Growth
  • AURA N/A
  • DHIL 9.28
  • 52 Week Low
  • AURA $4.35
  • DHIL $122.32
  • 52 Week High
  • AURA $12.38
  • DHIL $173.25
  • Technical
  • Relative Strength Index (RSI)
  • AURA 47.06
  • DHIL 45.49
  • Support Level
  • AURA $6.00
  • DHIL $134.01
  • Resistance Level
  • AURA $6.45
  • DHIL $146.60
  • Average True Range (ATR)
  • AURA 0.42
  • DHIL 3.14
  • MACD
  • AURA -0.05
  • DHIL -0.44
  • Stochastic Oscillator
  • AURA 14.39
  • DHIL 34.39

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About DHIL Diamond Hill Investment Group Inc.

Diamond Hill Investment Group Inc sponsors, markets, and provides investment advisory and related services to various U.S. and foreign clients including mutual funds, separate accounts, and private investment funds. The company's objective is to fulfill a fiduciary duty to clients and secondary objectives to achieve an adequate long-term return for shareholders. The company generates its revenue from Investment advisory and fund administration fees.

Share on Social Networks: